FDA OKs Spinal Cord Stimulation Devices for Chronic Back Pain
https://www.medscape.com/viewarticle/992053
The US Food and Drug Administration (FDA) has expanded the indication for Abbott Laboratories’ spinal cord stimulation (SCS) devices to include treatment of chronic back pain in patients who have not had, or are not eligible for, back surgery, the company has announced.
The new indication spans all of Abbott’s SCS devices in the US, which include the recharge-free Proclaim SCS family and the rechargeable Eterna SCS platform.
The devices feature the company’s proprietary, low-energy BurstDR stimulation waveform, a form of stimulation therapy that uses bursts of mild electrical energy without causing an abnormal tingling sensation to help disrupt pain signals before they can reach the brain, the company explains.
The expanded indication was supported by results from the DISTINCT study, which enrolled 270 adults suffering from severe, disabling chronic back pain for an average of more than 12 years and who were not eligible for surgery.
“This new indication for Abbott’s SCS devices, together with BurstDR stimulation, allows physicians the ability to identify and treat a new group of people, providing them with relief from chronic back pain,” Deer adds.
Filed under: General Problems
UGH. Not again.
proves to me,,it aint about our welfare,,its about the $$$$$$$$$$$$$,,,,which government employee,prez on down has ,,stock,” in this company????jmo,,maryw